Alterome Therapeutics, developing alteration-specific targeted therapies, $64M Series A with OrbiMed
Daasity, enables Consumer Product Brands to make better data-driven decisions, $15M Series A with VMG Partners
Zafrens, developing tools and generating insights at the interface of biology, chemistry, and engineering, $6.2M
ChargeNet Stations, EV software specializing in distributed energy resources, $6M Seed with Aligned Climate Capital
Radicle Science, offers an accelerated, non-FDA route to drug validation, $2.9M
Verity, offers plastic-free packaging solutions, $1.3M Seed

PhenoVista Biosciences, provides high content imaging-based phenotypic assay development and screening services, with BroadOak Capital Partners
Trust & Will, customized and easy estate planning, with UBS